Journal Home
Search for

Volume 46, Issue 4, Pages 642-647 (October 2007)


View previous. 9 of 57 View next.

Acute and chronic open conversion after endovascular aortic aneurysm repair: A 14-year review

Presented at the Thirty-fifth Annual Symposium of the Society for Clinical Vascular Surgery, Mar 21-24, Orlando, Fla.

Juan Carlos Jimenez, MD, Wesley S. Moore, MD, William J. Quinones-Baldrich, MDCorresponding Author Informationemail address

Received 14 March 2007; accepted 7 May 2007. published online 31 August 2007.

Objective

This study reviewed outcomes of patients requiring surgical conversion after endovascular abdominal aortic aneurysm (AAA) repair.

Methods

Records for all patients undergoing open conversion after endovascular AAA repair were reviewed.

Results

From 1993 to 2006, 574 patients underwent endovascular repair for AAA. Seventeen patients, including three patients who underwent prior endovascular repair at other centers, required surgical conversion with complete (n = 9) or partial graft removal (n = 8). Five patients required immediate conversion (acute), and 12 underwent delayed conversion 4 to 72 months after endovascular repair. Indications for acute conversion were large type I endoleak (n = 3, 60%), including one patient with graft migration, and retroperitoneal bleeding (n = 2, 40%). Indications for chronic conversion were endoleak with increasing aneurysm size (n = 9, 75%), stent fracture without endoleak (n = 1, 8%), delayed retroperitoneal bleeding (n = 1, 8%), and infection (n = 1, 8%). Suprarenal aortic cross-clamping was required in two patients (12%), and endograft components were retained in eight (47%). An aortic occlusion balloon placed through the body of the existing endograft facilitated proximal control in three patients. There were two perioperative deaths in the acute conversion group (2/5; 40%) and none in the delayed conversion group (P = .04). Five-year actuarial survival was 71.9%. Mean follow-up was 41.6 ± 32.2 months. Retained endovascular components in patients with partial graft removal remained stable during follow-up.

Conclusions

Surgical conversion after endovascular AAA repair can be performed without suprarenal clamping in most patients. Endovascular aortic control with a balloon avoids suprarenal exposure. Partial endograft removal in selected patients facilitates open conversion and appears durable. Acute conversion is associated with increased mortality.

Article Outline

Abstract

Materials and methods

Results

Discussion

Conclusion

Author Contributions

References

Copyright

The need for secondary interventions after endovascular aneurysm repair is still relatively frequent despite the development of newer-generation stent grafts. The reintervention rate at 1 year has been reported at 8% to 42% among different series.1, 2, 3, 4, 5 Most complications can be managed percutaneously6; however, open conversion may still be required. This is a potential source of increased morbidity in patients undergoing endovascular repair of abdominal aortic aneurysms (AAA). Previous reports have advocated the use of a midline approach with supraceliac clamping and extension of the aortotomy proximal to the renal arteries, with associated perioperative mortality as high as 20%.7, 8

We report our experience with 17 patients requiring acute or chronic open conversion after prior stent graft placement. We also describe the technical modification to avoid suprarenal exposure by an aortic occlusion balloon through the body of the endograft and inflated in the suprarenal visceral aorta for graft removal.

Materials and methods 

return to Article Outline

All patients who underwent open conversion after endograft placement for infrarenal aortic aneurysm between July 1993 and August 2006 at the University of California, Los Angeles were included in this retrospective review. Conversions were considered acute if performed immediately at the time of endovascular graft deployment. Conversions were considered chronic if performed during a separate hospitalization after initial endograft placement. The study excluded patients who did not have graft deployment at time of the initial operation who required open repair.

The medical records were retrospectively reviewed, and the preoperative risk factors were examined, including age, gender, aneurysm size, presence of documented coronary artery disease, congestive heart failure, prior myocardial infarction, pre-existing arrhythmia, hypertension, chronic obstructive pulmonary disease, pulmonary hypertension, smoking history, claudication, and hyperlipidemia. Presenting symptoms and indications for conversion were also noted. The intraoperative variables examined included type of skin incision, total estimated blood loss, need for suprarenal aortic clamping, use of an aortic balloon for hemostasis, placement of tube vs bifurcated graft, and partial vs complete device removal. Types of preoperative imaging were also specified.

The postoperative course was obtained from the medical record with documentation of major perioperative (<30 days) complications, including myocardial infarction, arrhythmia, respiratory failure, pleural effusion, renal failure, bleeding, and death. Elevated serial troponin levels documented myocardial infarction. Respiratory failure was defined as the need for reintubation after the initial postoperative extubation. Renal failure was considered a serum creatinine level >2.0 mg/dL or a rise in creatinine >1.0 mg/dL above baseline. Bleeding was defined as postoperative blood loss requiring reoperation. Perioperative death was defined as occurring before discharge or ≤30 days of surgery. Time to extubation, length of intensive care unit stay, days to feeding, and hospital length of stay were also noted.

Statistical analysis was performed where applicable using Excel 2003 (Microsoft, Redmond, Wash). For most categories, a two-tailed Student t test was used. Statistical significance was assigned to values at the P = .05 level.

This study was conducted with the approval of the University of California Institutional Review Board.

Results 

return to Article Outline

During a 14-year period, 17 open conversions (16 men, 1 woman) were performed at our institution with either partial or complete endograft removal (Table). Three (18%) patients had their initial endovascular repair performed at outside hospitals, and the remainder had their initial operation performed at our institution. Twelve (71%) patients underwent chronic conversions, and 5 (29%) patients underwent acute conversion after device placement.

Table.

Individual details of patients who underwent endograft conversion

PatientConversion dateAcute or chronicTime to conversionIndicationDeviceRetained componentsApproachPrior failed endovascular interventionOutcome
A7/18/93Chronic4 daysDelayed retroperitoneal bleedingAncureNoneTransperitonealNoneUnrelated death at 67 months
B10/1/93AcuteImmediateType I leakAncureNoneTransperitonealNoneAlive at 72 months; lost to follow up
C4/18/95Chronic17 monthsStent fracture with migrationAncureNoneTransperitonealNoneAlive at 101 months
D10/22/96Chronic37 monthsType I endoleak; increased aneurysm size; stent fractureAncureNoneTransperitonealNoneUnrelated death at 52 months
E2/19/97AcuteImmediateAortic ruptureAncureNoneTransperitonealNoneRespiratory failure; in-patient death
F2/25/97AcuteImmediateAortic ruptureAncureNoneTransperitonealNoneAlive at 85 months
G8/22/97AcuteImmediateType I endoleak; increased aneurysm sizeAncureNoneTransperitonealNoneAlive at 67 months
H12/2/97AcuteImmediateSevere graft migrationAncureNoneTransperitonealNoneMI on POD 5; in-patient death
I11/27/01Chronic15 monthsType I endoleak; increased aneurysm sizeAncureOne iliac limbRetroperitonealProximal placement of Palmaz stentAlive at 41 months
J10/23/02Chronic56 monthsType II endoleak; increased aneurysm sizeAncureTwo iliac limbsRetroperitonealEmbolization of patent iliolumbar and lumbar arteriesAlive at 6 months; lost to follow up
K11/5/02Chronic13 monthsInfected endograftAneuRxNoneRetroperitonealNoneAlive at 43 months
L11/6/02Chronic56 monthsType II endoleak; increased aneurysm sizeAncureTwo iliac limbsRetroperitonealCoil embolization of IMAAlive at 41 months
M8/20/03Chronic32 monthsType II and type III endoleaks; increased aneurysm sizeAncureTwo iliac limbsRetroperitonealProximal placement of Palmaz stent, coil embolization of IMA and lumbar arteriesDeath at 3 months; renal failure complications
N4/27/04Chronic41 monthsType II endoleak; increasing aneurysm sizeAncureTwo iliac limbsRetroperitonealEmbolization of patent iliolumbar and pudendal artery branchesAlive at 28 months
012/5/05Chronic72 monthsLarge type I endoleak; increasing aneurysm sizeUnknown (placed in China)Two iliac limbsRetroperitonealNoneAlive at 15 months
P8/7/06Chronic14 monthsType II and type IV endoleak; increasing aneurysm sizeZenithTwo iliac limbsRetroperitonealEmbolization of patent lumbar arteries and IMAAlive at 2 months; lost to follow-up
Q10/6/06Chronic22 monthsType II endoleak; increasing aneurysm sizeExcluderTwo iliac limbs, proximal endograftRetroperitonealEmbolization of patent iliolumbar arteries; relining with new endograftAlive at 6 months

MI, Myocardial infarction; IMA, Inferior mesenteric artery; POD, postoperative day.

The mean patient age was 77.6 ± 6.2 years. Twelve patients (71%) had pre-existing coronary artery disease, 15 (88%) were medically treated for hypertension, 4 (24%) sustained prior myocardial infarction, 7 (41%) had pre-existing cardiac arrhythmia, 2 (12%) had type II diabetes, 15 (88%) had a prior smoking history, 4 (24%) had chronic obstructive pulmonary disease, and 1 (6%) had moderate pulmonary hypertension. One patient (6%) had preoperative renal insufficiency (creatinine >2.0 mg/dL). No significant differences were noted in age or preoperative risk factors between the acute and chronic conversions groups.

The mean aneurysm size at conversion was 7.0 ± 1.4 cm. The mean sizes in the acute and chronic groups were 6.5 ± 0.9 and 7.1 ± 1.6 cm, respectively (P = .45). Mean time to conversion in the chronic group was 26.4 ± 25.0 months. Preoperative computed tomography (CT) scans were obtained in 17 (100%) patients, and 13 (76%) had preoperative aortic angiography. Indications for the five acute conversions were intraoperative aortic rupture (n = 2, 40%) and type I endoleak (n = 3, 60%), including one with complete graft migration into the aneurysm sac after deployment, noted intraoperatively. All acute conversions were performed at the time of attempted endovascular repair. Except for the two patients with acute aneurysm rupture, all other patients in the acute conversion group were hemodynamically stable.

Indications for chronic conversions were type I endoleak in three (25%), type II endoleak in five (42%), and one patient (8%) each with type III endoleak, type IV endoleak, stent fracture without endoleak, delayed retroperitoneal bleeding, and infection. One patient (8%) with an enlarging aneurysm sac after initial endovascular repair had no evidence of endoleak intraoperatively or angiographically and the increasing size was attributed to endotension. One patient was found to have type II and type III endoleak during operative exploration, and one had type II and type IV endoleaks. The type IV endoleak was not visualized on preoperative imaging but consisted of brisk bleeding through the interstices of the graft material at an attachment site to the metallic framework. All patients converted for endoleak, regardless of type, were noted to have increasing size of the aneurysm sac on serial CT scans.

Specific stent grafts removed included Ancure (Guidant, Menlo Park, Calif) in 13 patients (76%), and Zenith (Cook, Bloomington, Ind), Excluder (Gore, Flagstaff, Ariz) and Aneurx (Medtronic, Minneapolis, Minn) devices in one patient each. The remaining patient who presented for late conversion underwent prior stent graft placement in China and the specific device used was unclear.

The mean time to open conversion (from date of original operation) was 26.5 ± 25.0 months. The mean estimated intraoperative blood loss was 882.0 ± 565.0 mL. No statistically significant difference was noted between groups. Total mean operative time for both groups was 368.3 ± 91.2 minutes. A statistically significant increase was noted in the overall operative time in the acute group compared with the chronic group (447.0 ± 75.3 minutes vs 337.2 ± 74.0 minutes; P = .02).

A retroperitoneal approach was used in nine (53%) patients, all of which were chronic, elective conversions. No retroperitoneal incisions were performed in the acute conversion group. Transperitoneal midline laparotomy was used in seven patients (41%): five in the acute conversion group (29%) and two (12%) in the chronic conversion group. One patient (6%) underwent a bilateral subcostal incision for exposure.

Suprarenal aortic crossclamping was required in one patient (6%) and, in three patients (18%) in the chronic conversion group, aortic control was achieved by inflating an intraluminal aortic occlusion balloon proximal to the endograft before opening the aneurysm. The stent graft was completely removed in nine patients (53%). In eight patients (47%), one or both of the iliac limbs were retained and used to sew a distal graft-to-graft anastomosis. No kinking of distal endograft limbs was noted. No patients required hypogastric ligation with extension of the distal anastomosis to the external iliac arteries.

In one patient (5%) with a type II endoleak and enlarging aneurysm, the proximal portion of the graft was retained and used for the new proximal graft–to–graft/aorta anastomosis. This patient had a proximal Excluder endograft that was well incorporated, without evidence of endoleak, and transection 5 cm distal to the attachment zone allowed for infrarenal clamping. A bifurcated graft was used in 10 patients (59%) for aortic reconstruction and a tube graft was used in 6 (35%). In the patient who underwent explant for chronic graft infection, an axillobifemoral bypass was performed before abdominal exploration and complete graft removal.

The 5-year actuarial survival was 71.9%. Two patients (12%) who underwent acute conversion died perioperatively of a myocardial infarction on postoperative day 5 and acute respiratory failure secondary to an aspiration on postoperative day 4. There were no intraoperative deaths and no perioperative deaths in patients who underwent late chronic conversion.

The mean number of days for mechanical ventilation was 1.0 ± 1.2 days in the acute conversion group and 0.58 ± 0.8 days in the chronic conversion group (P = .4). Mean days to feeding were 7.0 ± 0.0 days in the acute group and 3.7 ± 1.3 days in the chronic group (P = .001). Patients who underwent retroperitoneal repair had a statistically significant shorter time to feeding than patients who underwent transperitoneal repair (3.5 ± 1.2 vs 5.7 ± 1.8 days, P = .02) Of note, one patient in the chronic conversion group demonstrated a prolonged postoperative ileus and was found to have a malignant ampullary tumor. The patient later underwent a Whipple resection in the perioperative period. Because our goal was to compare the effects of conversion on postoperative ileus, the patient was excluded from this comparison.

No patients required reoperation ≤30 days. One patient (6%) presented with a pleural effusion and required chest tube placement, with subsequent resolution.

The mean hospital length of stay was 9.6 ± 6.4 days, with no significant difference between the two groups. There was no significant difference in length of stay between patients who underwent retroperitoneal vs transperitoneal repair.

The mean follow-up period was 41.6 ± 32.2 months. Eight patients (47%) have been followed up with a postoperative CT scan demonstrating no evidence of aneurysm leak or expansion after open repair. As mentioned, one (6%) perioperative myocardial infarction resulted in respiratory failure and death, and one patient (6%) experienced respiratory failure and reintubation after and aspiration event. Both patients had undergone prior acute open conversion. In the chronic conversion group, acute postoperative renal failure requiring long-term hemodialysis developed in one patient, and one patient was readmitted 17 days later for chylous ascites that resolved after percutaneous drainage and bowel rest. No perioperative myocardial infarctions or episodes of respiratory failure occurred in the chronic conversion patients.

Discussion 

return to Article Outline

Few reported series have focused on the clinical consequences of open conversion and graft removal after endovascular AAA repair.5, 9, 10, 11 This operation has traditionally been associated with poor outcomes and high mortality. An early review by May et al,9 reported a 17% incidence of renal failure requiring hemodialysis and a 17% procedure-related mortality after open conversion. Lyden et al10 reported a 4.5% incidence of open conversion during a 4-year period. All patients underwent elective, late open conversions. Supraceliac aortic cross-clamping was performed in all patients in their series. The mean operative blood loss was 4700 mL, and the mean hospital length of stay was 19.8 days. Extension of the aortotomy proximal to the renal ostia was required in two patients to facilitate removal of the proximal portion of the graft, and the perioperative mortality was 20%. In a review of 11 patients, Lipsitz et al,11 reported 100% mortality (2/2) in patients who required supraceliac aortic clamping during open late conversion.

In a recent series by Verzini et al,5 nine early conversions and 29 late conversions were reported. The mortality in the acute conversion group was 22%. No late actuarial survival was reported. Most of the acute conversions were attributed to vessel wall calcification and failed cannulation. These patients were not included in our series. Of the 29 late conversions that were performed, only 17% underwent attempted secondary endovascular interventions before open conversion. In our series, chronic conversion group, most patients were converted only after failed secondary endovascular interventions.

The effects of prolonged suprarenal aortic clamp times during open aortic aneurysm repair and increased perioperative mortality have been documented.12 Avoidance of suprarenal clamping in our series likely contributes to the absence of perioperative morbidity and mortality in the chronic conversion group. Published series have advocated suprarenal clamping during conversion because of proximal fixators associated with various stent graft models and their proximity to the infrarenal neck of the aneurysm (ie, Vanguard, Boston Scientific, Natick, Mass; Talent, Medtronic AVE, Santa Rosa, Calif; Ancure, Guidant, Menlo Park, Calif.).10 The difficulty in removing these proximal attachment systems can contribute to prolonged suprarenal clamp times, prolonged renal ischemia, and damage to the adjacent aortic wall, further complicating repair. In our series, 13 (76%) of 17 patients underwent explant of previously placed Ancure grafts, a first-generation stent graft that contained angled proximal metal attachments hooks and a self-expanding cylindrical metal frame.

Certain technical modifications in selected patients have contributed to the improved results in our chronic conversion group. Once dissection of the proximal aneurysm neck is achieved, we use a 33-mm aortic occlusion balloon (Boston Scientific) placed in a 14F sheath (Cook), through the anterior wall of the stent graft, and position the device at the level of the suprarenal aorta (Fig 1, A and B) The balloon inflation allows proximal vascular control and the ability to open the aneurysm sac completely for full exposure of the stent graft without the need for operative exposure of the visceral aorta. This technique also allows removal of any proximal metal barbs or hooks without interference from an adjacent or superimposed aortic cross-clamp at this time.


View full-size image.

Fig 1. A and B, Insertion of an arterial sheath through the body of the existing endograft and inflation of an aortic occlusion balloon in proximal aorta for removal of prosthesis.


Once the graft is removed, a cross-clamp can be placed across the infrarenal aneurysm neck and clamped after balloon removal. We advocate the use of this technique instead of suprarenal aortic cross-clamping whenever possible. If the patient has a large type I endoleak, temporary partial clamping of the neck, opening the aneurysm, and then inserting the balloon would be the recommended sequence. Alternatively, placement of an aortic occlusion balloon through a femoral approach can be used in cases where opening the aneurysm sac before aortic control is not an option.

The presence of infection clearly mandates complete removal of the stent graft and all components and reconstruction with an extra-anatomic bypass or cryopreserved allograft. In the absence of infection, we prefer to selectively remove nonfunctional graft components and keep the proximal portion of the endograft body or distal limbs in place when these components appear sealed, free of kinking, and well incorporated. After difficult graft removal, the arterial wall may become thin and denuded, making an anastomosis more complicated and increasing the chances of anastomotic bleeding; thus, preservation of well-incorporated components is preferable, allowing a graft-to-graft anastomosis (Fig 2). This is particularly important when suprarenal fixation is present. If it is not necessary to remove the proximal portion of these devices, graft transection and inclusion of both the arterial wall and the endograft components in the anastomosis is best. Follow-up has demonstrated the durability of this selective approach.


View full-size image.

Fig 2. Preservation of iliac limbs from the existing endograft facilitates open conversion.


The two perioperative deaths (40%) in the acute group in this series highlight the significant morbidity associated with immediate open conversion, despite the avoidance of suprarenal clamping, and compare favorably with published reports.7, 11 The disadvantages of immediate open conversion include difficult positioning for a retroperitoneal approach, especially if the patient is hemodynamically unstable. In our series, immediate conversion was associated with longer operative times and an increased risk of perioperative death compared with the delayed conversion group. Both were statistically significant. The benefits of retroperitoneal exposure in terms of shortening overall length of hospital stay and decreasing postoperative respiratory failure have been described.13, 14 In this series, patients who underwent transperitoneal exposure demonstrated increased postoperative ileus compared with retroperitoneal exposure. No difference was noted in hospital length of stay between these two groups.

Patients who undergo acute open conversion after endograft deployment and malpositioning or with a major endoleak have received nephrotoxic contrast agents that may contribute to perioperative renal dysfunction, especially if prolonged suprarenal clamping becomes necessary. Progression to immediate open repair in otherwise stable patients should thus be aborted, if possible, and planned for delayed elective repair.

The need for late conversion based on our experience was about 2% at 5 years (Fig 3). Considering that most of the explanted devices were Ancure, a device system that lacked ancillary components to correct some of the issues that led to conversion, suggests that the need for open repair after endovascular aneurysm repair will likely be lower in the future.


View full-size image.

Fig 3. Cumulative survival after endograft conversion.


Conclusion 

return to Article Outline

Surgical conversion after endovascular AAA repair can be achieved without suprarenal clamping in most patients. Endovascular control with a balloon reduces the need for suprarenal exposure and should be used instead of suprarenal aortic cross-clamping whenever possible. Partial endograft removal in selected patients facilitates open conversion and appears durable. Retroperitoneal exposure is associated with decreased postoperative ileus after endograft conversion. Acute conversion appears to increase perioperative mortality. Long-term results with improving technology will likely reduce the need for open conversion after endovascular repair of aortic aneurysms.

Author Contributions 

return to Article Outline


Conception and design: JJ, WQ

Analysis and interpretation: JJ, WQ, WM

Data collection: JJ

Writing the article: JJ, WM, WQ

Critical revision of the article: WQ

Final approval of the article: WQ

Statistical analysis: JJ, WQ

Obtained funding: JJ, WQ

Overall responsibility: WQ

References 

return to Article Outline

1. 1Greenberg RK, Chuter TA, Lawrence-Brown M, Haulon S, Nolte LZenith Investigators. Zenith AAA endovascular graft: intermediate-term results of the US multicenter trial. J Vasc Surg. 2004;39:1209–1218. Abstract | Full Text | Full-Text PDF (273 KB) | CrossRef

2. 2Moore WS, Matsumara JS, Makaroun MS, Katzen BT, Deaton DH, Decker M, et al. Five-year interim comparison of the Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg. 2003;38:46–55. Abstract | Full Text | Full-Text PDF (293 KB) | CrossRef

3. 3Hobo R, Buth JEurostar Collaborators. Secondary interventions following endovascular abdominal aortic aneurysm repair using current endografts (A Eurostar report). J Vasc Surg. 2006;896–902.

4. 4Sampram EK, Karafa MT, Mascha EJ, Clair DG, Greenberg RK, Lyden SP, et al. Nature, frequency, and predictors of secondary procedures after endovascular repair of abdominal aortic aneurysm. J Vasc Surg. 2003;37:930–937. Abstract | Full Text | Full-Text PDF (123 KB) | CrossRef

5. 5Verzini F, Cao P, De Rango G, Parlani G, Xanthopoulos D, Iacono G, et al. Conversion to open repair after endografting for abdominal aortic aneurysm: causes, incidence and results. Eur J Vasc Surg. 2006;31:136–142.

6. 6Carpenter JP, Baum RA, Barker CF, Golden MA, Velzquez OC, Mitchell ME, et al. Durability of benefits of endovascular versus conventional abdominal aortic aneurysm repair. J Vasc Surg. 2002;35:222–228. Abstract | Full Text | Full-Text PDF (77 KB) | CrossRef

7. 7Jacobowitz GR, Lee AM, Riles TS. Immediate and late explantation of endovascular aortic grafts: the endovascular technologies experience. J Vasc Surg. 1999;29:309–316. Abstract | Full Text | Full-Text PDF (74 KB) | CrossRef

8. 8de Vries JP, van Herwaarden JA, Overtoom TT, Vos JA, Moll FL, van de Pavoordt ED. Clinical outcome and technical considerations of late removal of abdominal aortic endografts: 8-year single-center experience. Vascular. 2005;13:135–140. MEDLINE | CrossRef

9. 9May J, White GH, Waugh R, Stephen M, Sieunarine K, Harris JP. Conversion from endoluminal to open repair of abdominal aortic aneurysm: a hazardous procedure. Eur J Vasc Endovasc Surg. 1997;14:4–11. Abstract | Full-Text PDF (7136 KB) | CrossRef

10. 10Lyden SP, McNamara JM, Sternbach Y, Illig KA, Waldman DL, Green RM. Technical considerations for late removal of aortic endografts. J Vasc Surg. 2002;36:674–678. Abstract | Full-Text PDF (143 KB) | CrossRef

11. 11Lipsitz EC, Ohki T, Veith FJ, Suggs WD, Wain RA, Rhee SJ, et al. Delayed open conversion following endovascular aortoiliac aneurysm repair: partial (or complete) endograft preservation as a useful adjunct. J Vasc Surg. 2003;38:1191–1198. Abstract | Full Text | Full-Text PDF (363 KB) | CrossRef

12. 12Bauer EP, Redaelli C, von Segesser LK, Turina MI. Ruptured abdominal aortic aneurysms: predictor for early complications and death. Surgery. 1993;114:31–35. MEDLINE

13. 13Quinones-Baldrich WJ, Garner C, Caswell D, Ahn SS, Gelabert HA, Machleder HI, et al. Endovascular, transperitoneal, and retroperitoneal abdominal aortic aneurysm repair: results and costs. J Vasc Surg. 1999;30:59–67. Abstract | Full Text | Full-Text PDF (77 KB) | CrossRef

14. 14Rigberg DA, Dorafshar A, Sridhar A, Quinones-Baldrich W, Moore WS. Abdominal aortic aneurysm: stent graft vs. clinical pathway for direct retroperitoneal repair. 2004;139:941–944.

Division of Vascular Surgery, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, Calif

Corresponding Author InformationReprint requests: William Quinones-Baldrich, MD, 200 Medical Plaza, Ste 510-6, Los Angeles, CA 90095-6908.

 Competition of interest: none.

PII: S0741-5214(07)00958-5

doi:10.1016/j.jvs.2007.05.030


View previous. 9 of 57 View next.